U.S. Department of Commerce Confirms Low-Value Sales of L-Lysine from China

Estimated reading time: 3 minutes

The U.S. Department of Commerce has released its final findings on the importation of L-lysine from the People’s Republic of China. They have found that this important animal feed ingredient is being sold in the United States at less than fair value.

Investigation Details

The investigation looked at sales from October 1, 2024, to March 31, 2025. The investigation and reporting were completed by the International Trade Administration under the Department of Commerce.

Key Players and Companies

Several key companies from China were involved in the investigation. These include Changchun Dahe Bio Technology Development Co., Eppen Asia Pte. Ltd., and Shouguang Golden Corn Biotechnological Co. Ltd. The Eppen Group and Zhengzhou Longgu Trading Co. Ltd. were particularly notable.

Findings and Results

The Department of Commerce used a method called “adverse facts available” to decide the outcomes, especially for companies that did not co-operate fully, like Longgu and Heshu. The investigation revealed dumping margins, which are differences between the prices in China and the U.S., suggesting that L-lysine was sold in the U.S. at unfairly low prices.

Implications and Actions

As a result of these findings, the Department of Commerce will continue to suspend the entry of this product into the U.S. The cash deposit rates have been set for these imports. Companies will have to pay duties when they bring in L-lysine from China, ensuring fair pricing.

What Happens Next

The International Trade Commission (ITC) will decide if these imports have hurt U.S. businesses. If they conclude that they have caused harm, the duties will remain. If not, the investigation’s outcomes will change.

For those involved in the importation and use of lysine, this decision is crucial. It aims to protect the U.S. market from unfairly priced imports and ensure fair trading practices.

Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.